FR3059429B1 - PROCESS FOR IMPUTING A NON-NEGATIVE RESPONSE OBTAINED IN A REVERSE MUTATION TEST ON BACTERIA, CARRIED OUT FROM A PHARMACEUTICAL, COSMETIC OR NUTRITIONAL PREPARATION, AT LEAST ONE CONSTITUENT IDENTIFIED AS MUTAGEN IN VITRO - Google Patents
PROCESS FOR IMPUTING A NON-NEGATIVE RESPONSE OBTAINED IN A REVERSE MUTATION TEST ON BACTERIA, CARRIED OUT FROM A PHARMACEUTICAL, COSMETIC OR NUTRITIONAL PREPARATION, AT LEAST ONE CONSTITUENT IDENTIFIED AS MUTAGEN IN VITRO Download PDFInfo
- Publication number
- FR3059429B1 FR3059429B1 FR1661745A FR1661745A FR3059429B1 FR 3059429 B1 FR3059429 B1 FR 3059429B1 FR 1661745 A FR1661745 A FR 1661745A FR 1661745 A FR1661745 A FR 1661745A FR 3059429 B1 FR3059429 B1 FR 3059429B1
- Authority
- FR
- France
- Prior art keywords
- bacteria
- imputing
- mutagen
- cosmetic
- vitro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000894006 Bacteria Species 0.000 title abstract 3
- 230000035772 mutation Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000000470 constituent Substances 0.000 title 1
- 239000002537 cosmetic Substances 0.000 title 1
- 238000000338 in vitro Methods 0.000 title 1
- 239000003471 mutagenic agent Substances 0.000 title 1
- 231100000707 mutagenic chemical Toxicity 0.000 title 1
- 230000003505 mutagenic effect Effects 0.000 title 1
- 235000016709 nutrition Nutrition 0.000 title 1
- 230000004913 activation Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 239000012085 test solution Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
- G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Procédé de préparation et de fractionnement d'une solution d'essai adaptée pour subir un test de mutation réverse sur bactéries en présence et/ou en absence d'activation métabolique exogène, et procédé permettant d'imputer une réponse non négative obtenue lors d'un premier test de mutation réverse sur bactéries.Process for preparing and fractionating a test solution suitable for undergoing a reverse mutation test on bacteria in the presence and / or absence of exogenous metabolic activation, and process for imputing a non-negative response obtained during a first reverse mutation test on bacteria.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1661745A FR3059429B1 (en) | 2016-11-30 | 2016-11-30 | PROCESS FOR IMPUTING A NON-NEGATIVE RESPONSE OBTAINED IN A REVERSE MUTATION TEST ON BACTERIA, CARRIED OUT FROM A PHARMACEUTICAL, COSMETIC OR NUTRITIONAL PREPARATION, AT LEAST ONE CONSTITUENT IDENTIFIED AS MUTAGEN IN VITRO |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1661745 | 2016-11-30 | ||
FR1661745A FR3059429B1 (en) | 2016-11-30 | 2016-11-30 | PROCESS FOR IMPUTING A NON-NEGATIVE RESPONSE OBTAINED IN A REVERSE MUTATION TEST ON BACTERIA, CARRIED OUT FROM A PHARMACEUTICAL, COSMETIC OR NUTRITIONAL PREPARATION, AT LEAST ONE CONSTITUENT IDENTIFIED AS MUTAGEN IN VITRO |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3059429A1 FR3059429A1 (en) | 2018-06-01 |
FR3059429B1 true FR3059429B1 (en) | 2020-09-04 |
Family
ID=58054268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1661745A Active FR3059429B1 (en) | 2016-11-30 | 2016-11-30 | PROCESS FOR IMPUTING A NON-NEGATIVE RESPONSE OBTAINED IN A REVERSE MUTATION TEST ON BACTERIA, CARRIED OUT FROM A PHARMACEUTICAL, COSMETIC OR NUTRITIONAL PREPARATION, AT LEAST ONE CONSTITUENT IDENTIFIED AS MUTAGEN IN VITRO |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR3059429B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3133860A1 (en) * | 2022-03-23 | 2023-09-29 | Genevolution | Process for detecting the mutagenic nature of chemical compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1620569B1 (en) * | 2003-04-26 | 2009-12-09 | Merck & Co., Inc. | A forward mutation assay based on 5-fluorouracil resistance |
EP2258391A1 (en) * | 2009-06-05 | 2010-12-08 | Stallergenes S.A. | Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids |
FR2950532B1 (en) * | 2009-09-30 | 2012-06-22 | Natura Cosmeticos Sa | PROCESS FOR THE PREPARATION OF AN EXTRACT OF PLANTS OF THE GENUS SCLEROLOBIUM, COSMETIC AND PHARMACEUTICAL COMPOSITION COMPRISING THIS EXTRACT AND THE USE OF SAID EXTRACT |
-
2016
- 2016-11-30 FR FR1661745A patent/FR3059429B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
FR3059429A1 (en) | 2018-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4321627A3 (en) | Spatially distinguished, multiplex nucleic acid analysis of biological specimens | |
BR112015026766A2 (en) | hydroxycarboxylic acid processing for polymers | |
BR112017004663A2 (en) | motor task analysis system and method | |
FR3056989B1 (en) | L-AMINO ACID PRODUCTION PROCESS | |
EP4296365A3 (en) | Processes for conversion of biologically derived mevalonic acid | |
PE20190517A1 (en) | PHARMACEUTICAL PREPARATION ANTI-AGING | |
FR3046541B1 (en) | ACTIVE PRINCIPLE OBTAINED FROM OPHIOPOGON JAPONICUS FOR THE TREATMENT OF ATOPIC DERMATITIS | |
FR2992849B1 (en) | BLADE FOR PREPARING AN ENDOTHELIAL GRAFT AND PROCESS FOR PREPARING THE SAME | |
BR112019000975A2 (en) | Single Use Food Preparation Container Method, System and Set | |
FR3059429B1 (en) | PROCESS FOR IMPUTING A NON-NEGATIVE RESPONSE OBTAINED IN A REVERSE MUTATION TEST ON BACTERIA, CARRIED OUT FROM A PHARMACEUTICAL, COSMETIC OR NUTRITIONAL PREPARATION, AT LEAST ONE CONSTITUENT IDENTIFIED AS MUTAGEN IN VITRO | |
WO2016014612A3 (en) | Compositions and methods for the diagnosis of rheumatoid arthritis | |
BR112018074315A2 (en) | method for producing oil with reduced saturated fatty acids. | |
FR2971719B1 (en) | DEVICE FOR COATING A FLUID-PRODUCING OBJECT WITH AN ASSOCIATED DISTRIBUTION AND PROCESSING ASSEMBLY | |
BR112016028185A2 (en) | method for producing an 1-amino acid. | |
WO2015186105A3 (en) | Method for producing tolerogenic dendritic cells with specific antigens and uses thereof | |
WO2017205598A8 (en) | Processing blood samples to detect target nucleic acids | |
FR2957076B1 (en) | PROCESS FOR THE PRODUCTION OF PYRROLIDONECARBOXYLIC ACID OR A SALT THEREOF, PYRROLIDONECARBOXYLIC ACID SO OBTAINED AND COSMETIC CONTAINING THE SAME | |
FR3032198B1 (en) | VALORIZATION OF NOBLE PRODUCTS IN A PROCESS FOR THE PRODUCTION OF (METH) ACRYLIC ESTER. | |
FR3016637B1 (en) | GLYCOSAMINOGLYCANE IN VIVO PRODUCTION PROCESS | |
ES2499590T3 (en) | Fermentation process with GH61 polypeptides | |
FR3080377B1 (en) | PROCESS FOR PREPARING ALIPHATIC POLYESTERAMIDES | |
RU2012111034A (en) | METHOD FOR DETERMINING THE NUMBER OF MICRO-ORGANISMS IN THE AIR | |
FR3027905B1 (en) | PROCESS FOR POLYMERIZING (METH) ACRYLIC ACID IN SOLUTION. | |
FR3049169B1 (en) | PROCESS FOR THE PRODUCTION OF MILK SKIN AND THE FORMULATION OF FOODSTUFFS BASED ON MILK SKIN | |
BR112018074714B8 (en) | PROCESS FOR FORMING NUTRITIONAL PRODUCTS ENRICHED WITH IRON |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
EXTE | Extension to a french territory |
Extension state: PF |
|
PLSC | Publication of the preliminary search report |
Effective date: 20180601 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 7 |
|
PLFP | Fee payment |
Year of fee payment: 8 |